Related Experiment Video
Updated: Apr 21, 2026
07:08
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
8.9K
Polyglutamine Aggregation in Huntington Disease: Does Structure Determine Toxicity?
Guylaine Hoffner1, Philippe Djian2
1Laboratoire de Physiologie Cérébrale, Centre National de la Recherche Scientifique, Université Paris Descartes, 45 rue des Saints Pères, 75006, Paris, France.
Molecular Neurobiology
|October 23, 2014
Summary
Huntington disease involves mutated huntingtin protein aggregation in the central nervous system, leading to neuronal death. Understanding the diverse structures of these protein aggregates is key to developing targeted therapies.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Huntington disease is a dominantly inherited neurodegenerative disorder.
- It is caused by the expansion of a polyglutamine tract in the huntingtin protein.
- This expansion leads to a toxic gain of function and neuronal cell death.
Purpose of the Study:
- To investigate the structural heterogeneity of huntingtin protein aggregates in Huntington disease.
- To explore the potential link between aggregate structure and neurotoxicity or neuroprotection.
- To identify specific toxic aggregate structures for targeted therapeutic intervention.
Main Methods:
- Proteolytic processing of expanded huntingtin.
- Abnormal protein folding and aggregation.
- Structural characterization of polyglutamine-containing aggregates.
Main Results:
- Expanded huntingtin undergoes proteolysis and forms structurally diverse aggregates.
- These aggregates include oligomers, fibrils, and inclusions.
- Structural heterogeneity may explain paradoxical toxic or protective roles of aggregates.
Conclusions:
- The structural diversity of huntingtin aggregates is a critical factor in Huntington disease pathogenesis.
- Targeting specific toxic aggregate structures offers a potential therapeutic strategy.
- Further research into aggregate structures could lead to novel prophylactic or therapeutic drugs.
More Related Videos
Related Concept Videos
01:21Huntington Disease l: Introduction
14
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
14
03:03Amyloid Fibrils
10.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
10.1K